Incidence, risk factors and outcome of histological transformation in follicular lymphoma. - Wikidata - awgldk - TriplyDB

Incidence, risk factors and outcome of histological transformation in follicular lymphoma.

Incidence, risk factors and outcome of histological transformation in follicular lymphoma.

http://www.wikidata.org/entity/Q45286370

about

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.Amplification of 2p as a genomic marker for transformation in lymphoma.Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.Radiation therapy for localized duodenal low-grade follicular lymphoma.FDG-PET imaging in hematological malignancies Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.Follicular lymphomas and their transformation: Past and current research.Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.Histologic transformation in marginal zone lymphomas†.Life expectancy of young adults with follicular lymphoma.Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas.Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.Gastrointestinal follicular lymphoma: Current knowledge and future challenges.Transformed follicular lymphoma.The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma.Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitals

P2860

Q28073262-E0A577AD-E5DC-4480-83F8-C30CEEF12D7A Q33670880-54D9263C-022B-4334-A1A0-D4A4D78B0CC8 Q33759661-C6F54C87-B6B9-483A-96E3-F161D9084753 Q33766616-E9829568-0938-4208-962A-6584E99AB1EF Q35204449-25F9C79C-FAE5-4E91-A748-7E4E3FDF5558 Q35979057-8CD6E272-E64E-454B-9601-0EC567BD070B Q37132380-3912DFA6-74C6-4218-90DF-0D204935F3ED Q37152169-B3B0458D-2079-4265-85F3-B93E063E6478 Q37632114-0F790FEB-0CD9-447B-9CFF-84FB7F335E55 Q38032198-19C384FB-026C-4CF9-9AA1-A444DEABA297 Q39281793-A56F6BFB-A755-4202-9FE8-49C6940F5091 Q39290214-B1BEAA53-ACC0-41EE-960C-31B7D8612D25 Q39685859-46880E97-B60B-4097-A25F-69F7454D452C Q40374056-CAEBDB89-4909-4A5E-AB6E-4D6816F719C3 Q40481449-33538F42-2F66-42B1-9C6F-A4BC98F51642 Q41326723-74998F62-7F7E-4816-B523-5F2A38944D06 Q41370330-B7CED9BB-5BBF-4B24-9BDC-6C8A4C6D3DB0 Q41489053-032F3FA6-2E1E-41A6-95F2-C95843C96721 Q42388537-25FA399B-39CD-4BBB-9816-7884C253AD47 Q43213072-2CE907CD-4FB9-49DC-AC7D-796328A54AE1 Q44035879-CC1C9EDC-36D2-458C-8378-6A00C5A1B729 Q47756618-421DE08C-976B-4A91-A4AF-08F2D5232ADD Q47771789-EDA768CB-5987-4A33-82E2-6A6A503649FF Q48274743-1FFDAF44-9B34-4D94-8EFC-46C72FB6C334 Q50089414-83662F10-B523-4002-A2A7-746FD38D1F0D Q50436933-967E74F7-6146-45E6-AC68-AE049E4F3600 Q51005409-7B76EE9D-5B87-4715-BD00-91C334100B07 Q53227941-0C8E4A9F-0736-4D24-9194-C03B6FD674AD Q55026647-F0CC7471-830D-4D08-993E-73C31088CD7D Q58124869-1E0B04FB-98B8-4D19-B7D6-68C5151A37DE

P2860

Incidence, risk factors and outcome of histological transformation in follicular lymphoma.

http://www.wikidata.org/entity/Q45286370

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@en

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@nl

type

label

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@en

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@nl

prefLabel

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@en

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@nl

P1433

Q45286370-F699586C-8E52-4B42-B2D1-09EE2930FB01

P1476

Q45286370-83722918-828F-4E05-8AF3-8F04ED49F0E1

P2093

Q45286370-05EB7682-AE0E-464D-90DF-49767C97B5FB

Q45286370-3238B14D-A500-4325-A54E-A14C355035BA

Q45286370-33104949-3816-409E-9497-9682F6CACBD2

Q45286370-51AC7764-E6A7-4086-A691-E85E4938E58E

Q45286370-6F545227-2BF9-4016-8018-F7BE4A7C8204

Q45286370-C6FCD95A-491F-4733-9B0E-6BB7DCF91C95

Q45286370-D14A99D2-938A-4B58-AC95-41D305E6322C

Q45286370-DB568351-650E-4A84-A528-BC24C844979C

Q45286370-DDD45FAD-75D5-4E86-96C8-EE091D380566

Q45286370-E62507B8-FFED-453A-8731-4FE7F731AEFD

P2860

Q45286370-0273E582-5D82-402B-AD58-F66E96CF008A

Q45286370-0908F7F3-9C94-4F00-8FF3-FB26B527DB52

Q45286370-0B5064BB-1F9B-49BC-AD52-F65B2B86A58D

Q45286370-0CC2D975-E690-4708-BB33-B479060C1805

Q45286370-113A58D0-403A-4317-8F7A-3D04D75C8B91

Q45286370-18115A13-A229-468D-96C8-C77601C05AEE

Q45286370-18664B12-EAFD-4D16-9757-5092479A8B2B

Q45286370-22022604-003B-4350-8ACF-C289FB5C99CB

Q45286370-2E0712FE-0E3E-4DB4-A75D-6AA96C58FEFB

Q45286370-4847FD2B-48B2-4162-B4CA-0001AE50527D

P304

Q45286370-2CF25C88-5804-470E-ADB5-779236C4ADC7

P31

Q45286370-C8E1E3E6-EEBF-471B-B1A2-E043AEAF08E9

P356

Q45286370-2C6F866F-FE3A-4595-A4E6-59EFEC03EB9B

P407

Q45286370-926ACFAE-000D-4669-85B4-E2661004792E

P433

Q45286370-D35A3F42-7CB0-4872-839E-B167248E739E

P478

Q45286370-DCF8C990-459C-467E-9073-84F42B6DE393

P50

Q45286370-5B0A4B03-759C-4319-840D-31E917D7DB75

P577

Q45286370-869BCB3A-1BC4-438F-B5FF-DCEAF3C1AE58

P5875

Q45286370-9A161F18-5874-4D3D-82F7-B6B3DF2C2CE4

P698

Q45286370-0825C94E-4E1A-411B-A3B3-E336B7136900

P356

J.1365-2141.2012.09054.X

P1433

British Journal of Haematology

P1476

Incidence, risk factors and ou ...... mation in follicular lymphoma.

@en

P2093

Alden A Moccia

http://www.w3.org/2001/XMLSchema#string

Anastasios Stathis

http://www.w3.org/2001/XMLSchema#string

Annarita Conconi

http://www.w3.org/2001/XMLSchema#string

Carlotta Ponzio

http://www.w3.org/2001/XMLSchema#string

Chiara Lobetti-Bodoni

http://www.w3.org/2001/XMLSchema#string

Emanuele Zucca

http://www.w3.org/2001/XMLSchema#string

Franco Cavalli

http://www.w3.org/2001/XMLSchema#string

Luca Mazzucchelli

http://www.w3.org/2001/XMLSchema#string

Maddalena Motta

http://www.w3.org/2001/XMLSchema#string

Michele Ghielmini

http://www.w3.org/2001/XMLSchema#string

P2860

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma

The logrank test.

New treatment options have changed the survival of patients with follicular lymphoma.

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

Review of survival analyses published in cancer journals

Treatment strategies in follicular lymphomas: current status and future perspectives.

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation

P304

188-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2012.09054.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Bertoni

P577

2012-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221845821

http://www.w3.org/2001/XMLSchema#string

P698

22348437

http://www.w3.org/2001/XMLSchema#string